Dr Philippa Brice
Deputy Director
Philippa leads our policy engagement and external relations activity, as well as supporting corporate management and strategic development.
Experienced in policy relating to the use of innovations in healthcare, Philippa works with a wide range of stakeholders on projects and thought leadership in genomics and personalised and precision medicine, including establishing and running the All Party Parliamentary Group on Personalised Medicine between 2015 and 2020. She sits on the UK Pharmacogenetics and Stratified Medicine Network steering committee, and has expertise in biomedical charity and commercial governance, including patient support, safeguarding and health professional education.
With an MA in Natural Sciences (Pathology) from Christ’s College, Cambridge, Philippa did her doctoral research at the prestigious MRC Laboratory for Molecular Biology before moving to work in the pharmaceutical industry. She is a Member of the Chartered Institute of Public Relations.
- Reports
- Policy briefings
- Consultation responses
- Blogs
-
Making the most of genomics: supporting clinical research and care
-
Goldacre recommendations for making the most of health data for research
-
NHS reform plans: prevention, personalisation and personal responsibility
-
Calls to review regulation of direct-to-consumer genetic testing
-
New and improved innovation unit to lead on accelerated access
-
Underpinning medical innovation: the Life Sciences Industrial Strategy
-
All patients need faster access to useful medical innovations
-
NHS uptake of innovations: clinical researchers are not the answer
-
This time, it’s personal: health policy and disease prevention
-
Innovation for all? A challenge for the Department of Health
-
Controversial world first genetic modification of human embryos
-
Welcome UK moves to revolutionise uptake of innovations in healthcare
-
The shifting sands of direct-to-consumer genetic test regulation
-
Patients and genomics: dual drivers of health system change?
-
Obama’s precision medicine initiative: the future of healthcare?
-
Can the Scottish Genomes Partnership rival Genomics England?
-
UK public at odds with health profession on genetic testing of children
-
Implications for BRCA testing as Australian court upholds gene patents
-
Future-proofing UK diagnostic capacity for stratified medicine
-
Using science for health: lessons from Creutzfeldt-Jakob disease
-
A new risk-based approach for genetic test regulation in the US
-
Policy and health profession must adapt to personalised medicine
-
23andMe engages with the FDA on health-related genetic tests
- News
-
Legal ruling restricts international sharing of genomic data
-
Making science work for health: towards personalised prevention
-
UK Government must act to realise the full potential of genomics in the NHS
-
Unique science for health policy think-tank joins University of Cambridge
- Journal papers
-
From the lab to the maternity ward: how genetics can beat birth defects
The Guardian. 2014 July 9.
-
Familial Hypercholesterolaemia: a pressing issue for European health care
Aitman T, Brice P, Burton H, Edwards C, Humphries S.
Atherosclerosis. 2013 December; 231(2): 223-226
-
Realising the benefits of genetics for health
Brice P, Burton H, Stewart A, Wright C.
The Lancet. 2010 Oct; 23;376(9750):1370-1.
-
Knowledge sharing and 'genomic' healthcare
Brice P, Dutta I, Wallace S.
Nature Biotechnology. 2005; 23(2):169-70
-
The NHS in the era of genetics: implications for community practitioners
Community Practitioner. 2003;76(8):288-90